RAFA Trial Results: High Dose Rifampicin Tuberculosis treatment regimen to reduce 12 month mortality of TB/HIV co-infected patients

2018-02-05T17:02:04Z (GMT) by Corinne Merle
RAFA Trial Results: High Dose Rifampicin Tuberculosis treatment regimen to reduce 12 month mortality of TB/HIV co-infected patients - Corinne Merle.<br><br>This presentation was delivered at the 2017 INTERTB symposium, held at St George’s, University of London. The full collection of outputs from the meeting can be accessed from the link referenced below.